$REGN News Article - Dupixent (dupilumab) Late-breaking Pivotal Data Showing Significant Improvement in Eosinophilic Esophagitis Signs and Symptoms Presented for the First Time at Scientific Meetings
https://marketwirenews.com/news-releases/dupi...69982.html